Improving Antimycobacterial Activity of Pyridine-4-Carbohydrazide
Author Information
Author(s): Pflégr Václav, Konečná Klára, Stolaříková Jiřina, Ősterreicher Jan, Janďourek Ondřej, Krátký Martin
Primary Institution: Charles University
Hypothesis
Linking pyridine-4-carbohydrazide to other antimicrobial agents via oxocarboxylic acids will enhance its efficacy against mycobacteria.
Conclusion
The study found that many derivatives of pyridine-4-carbohydrazide exhibited potent antimycobacterial activity, outperforming the standard drug isoniazid.
Supporting Evidence
- Many derivatives exhibited potent antimycobacterial activity with MICs as low as ≤0.25 μM.
- Compounds were effective against multidrug-resistant strains at higher concentrations.
- The cytotoxicity assay indicated a favorable safety profile with no significant hemolysis at 125 μM.
Takeaway
Scientists combined a tuberculosis drug with other medicines to make it work better against germs that cause tuberculosis.
Methodology
The study synthesized various derivatives of pyridine-4-carbohydrazide and tested their antimycobacterial activity against different strains.
Limitations
The study primarily focused on in vitro results, and further in vivo studies are needed to confirm efficacy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website